Synergistic immune protection of exosomal T-cell epitope vaccine and antibody-inducing vaccine against SARS-CoV-2 in highly humanized mice.

Shen, Anran et al.·Frontiers in immunology·2026·

Quick Facts

Study Type

Not classified

Evidence

Not graded

Sample

Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:: Synergistic immune protection of exosomal T-cell epitope vaccine and antibody-inducing vaccine against SARS-CoV-2 in highly humanized mice.
Published In:: Frontiers in immunology, 17, 1729444 (2026)
Authors:: Shen, Anran, Zhu, Suyue, Li, Min(4), Zhao, Yu, Wu, Yandan, Zhang, Yue, Zhang, Jiejie, Han, Xuelian, Wang, Yuan, Zhao, Guangyu, Lv, Linli, Yin, Qi, Tang, Taotao
Database ID:: RPEP-16112

Evidence Hierarchy

Meta-Analysis / Systematic Review

Randomized Controlled Trial

Cohort / Case-Control

Cross-Sectional / ObservationalSnapshot without intervening

This study

Case Report / Animal Study

What do these levels mean? →

Cite This Study

RPEP-16112·https://rethinkpeptides.com/research/RPEP-16112

APA

Shen, Anran; Zhu, Suyue; Li, Min; Zhao, Yu; Wu, Yandan; Zhang, Yue; Zhang, Jiejie; Han, Xuelian; Wang, Yuan; Zhao, Guangyu; Lv, Linli; Yin, Qi; Tang, Taotao. (2026). Synergistic immune protection of exosomal T-cell epitope vaccine and antibody-inducing vaccine against SARS-CoV-2 in highly humanized mice.. Frontiers in immunology, 17, 1729444. https://doi.org/10.3389/fimmu.2026.1729444

MLA

Shen, Anran, et al. "Synergistic immune protection of exosomal T-cell epitope vaccine and antibody-inducing vaccine against SARS-CoV-2 in highly humanized mice.." Frontiers in immunology, 2026. https://doi.org/10.3389/fimmu.2026.1729444

RethinkPeptides

RethinkPeptides Research Database. "Synergistic immune protection of exosomal T-cell epitope vac..." RPEP-16112. Retrieved from https://rethinkpeptides.com/research/shen-2026-synergistic-immune-protection-of

Access the Original Study

View on PubMed View via DOI

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.

← Back to Research Database